Zobrazeno 1 - 6
of 6
pro vyhledávání: '"SHIMA, Nobukazu"'
Autor:
NOMURA, Norihiro, ITO, Takayoshi, SHINOHARA, Hiroki, SHIMA, Nobukazu, SATOU, Masashi, SAKUMA, Dai, EGUCHI, Junichi, URAGAMI, Naoyuki, DEGUCHI, Yoshio, YOKOYAMA, Noboru, INOUE, Haruhiro
Publikováno v:
The Showa University journal of medical sciences. 31(4):373-378
Hepatocellular carcinoma(HCC)is the sixth most commonly diagnosed cancer worldwide. Sorafenib is an oral multikinase inhibitor used in the palliative treatment of advanced HCC. However, there were no reported cases of complete response(CR)fro
Publikováno v:
SAE Transactions, 2001 Jan 01. 110, 427-431.
Externí odkaz:
https://www.jstor.org/stable/44718354
Autor:
SHIMA, Nobukazu, OHIKE, Nobuyuki, SUZUKI, Reika, NOROSE, Tomoko, ISOBE, Tomohide, SHIOKAWA, Akira, TAKEYAMA, Nobuyuki, TANAKA, Junichi, MURAKAMI, Masahiko, TAKIMOTO, Masafumi
Publikováno v:
The Showa University journal of medical sciences. 30(1):35-42
The relationship between the clinicopathological features and the grade of cellular dysplasia of the neoplastic glands in mass-forming gallbladder cancer was investigated. In this retrospective study, 41 mass-forming (≧1cm) gallbladder cancer s
Autor:
Ohike Nobuyuki, Shima Nobukazu :筆頭著者:責任著者, Tanaka Jun-ichi, Suzuki Reika, Norose Tomoko, Takimoto Masafumi, Murakami Masahiko, Takeyama Nobuyuki, Isobe Tomohide, Shiokawa Akira
Publikováno v:
The Showa University Journal of Medical Sciences. 30:35-42
Autor:
HAJIKANO, Seiya, HIROTA, Yuko, SHIMA, Nobukazu, SUZUKI, Reika, SAWADA, Terumasa, NAKAMURA, Seigo, Oike, Nobuyuki, NOUE, Haruhiro, TAKIMOTO, Masafumi
Publikováno v:
The Showa University journal of medical sciences. 29(2):181-192
The therapeutic effect found histologically after surgery following neoadjuvant chemotherapy (NAC) correlates with patient prognosis. Such correlations must consider the remaining invasive lesions as well as intra-ductal components and lymph node met
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.